(Q34463834)

2 August 2017

title

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse (English)

1 reference

2 August 2017

Sarah R Nesfield

1

1 reference

2 August 2017

Thomas C Williams

2

1 reference

2 August 2017

Debie J Hoivik

3

1 reference

2 August 2017

Richard T Miller

4

1 reference

2 August 2017

Jane S Allen

5

1 reference

2 August 2017

Krzysztof Selinger

6

1 reference

2 August 2017

Douglas Rickert

7

1 reference

2 August 2017

Michael J Santostefano

8

1 reference

2 August 2017

publication date

1 September 2005

1 reference

International Journal of Toxicology

2 August 2017

published in

1 reference

2 August 2017

volume

24

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

341-348

1 reference

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Evaluation of the newborn mouse model for chemical tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

PPARalpha agonist-induced rodent tumors: modes of action and human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Neonatal mouse model: review of methods and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Mitochondrial changes associated with glutathione deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

P53+/- hemizygous knockout mouse: overview of available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500210401

10.1080/10915810500210401

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference